CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-07 | Alland Leila Chief Medical Officer | Sale | −2,049 | $32.66 | $67K | 0 |
| 2021-07-07 | Alland Leila Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −4,000 | 361,850 | ||
| 2021-06-28 | Mack David Henry President and CEO | Exercise or conversion | +204 | $0.53 | $108 | 12,674 |
| 2021-06-28 | Mack David Henry President and CEO | Sale | −204 | $35.53 | $7K | 12,470 |
| 2021-06-28 | Mack David Henry President and CEO | Exercise or conversion · Stock Option (right to buy) | −204 | 474,870 | ||
| 2021-06-21 | LEVINE ARNOLD J Director | Sale | −3,389 | $33.22 | $113K | 420,453 |
| 2021-06-21 | LEVINE ARNOLD J Director | Sale | −111 | $34.09 | $4K | 420,342 |
| 2021-06-14 | Euclidean Capital LLC 10% owner | Sale | −4,699 | $34.11 | $160K | 474,363 |
| 2021-06-14 | Euclidean Capital LLC 10% owner | Sale | −6,593 | $34.11 | $225K | 665,696 |
| 2021-06-14 | Euclidean Capital LLC 10% owner | Sale | −7,141 | $34.11 | $244K | 720,999 |
| 2021-06-14 | Euclidean Capital LLC 10% owner | Sale | −24,726 | $34.11 | $843K | 2,496,554 |
| 2021-06-14 | Euclidean Capital LLC 10% owner | Sale | −1,260 | $34.11 | $43K | 127,099 |
| 2021-06-11 | Euclidean Capital LLC 10% owner | Sale | −2,324 | $33.80 | $79K | 479,062 |
| 2021-06-11 | Euclidean Capital LLC 10% owner | Sale | −3,262 | $33.80 | $110K | 672,289 |
| 2021-06-11 | Euclidean Capital LLC 10% owner | Sale | −3,533 | $33.80 | $119K | 728,140 |
| 2021-06-11 | Euclidean Capital LLC 10% owner | Sale | −12,237 | $33.80 | $414K | 2,521,280 |
| 2021-06-11 | Euclidean Capital LLC 10% owner | Sale | −621 | $33.80 | $21K | 128,359 |
| 2021-06-10 | Euclidean Capital LLC 10% owner | Sale | −2,183 | $32.68 | $71K | 481,386 |
| 2021-06-10 | Euclidean Capital LLC 10% owner | Sale | −3,063 | $32.68 | $100K | 675,551 |
| 2021-06-10 | Euclidean Capital LLC 10% owner | Sale | −3,317 | $32.68 | $108K | 731,673 |
Page 12 of 23 · 457 trades